XT
BCYC

XTX Topco’s Bicycle Therapeutics BCYC Stock Holding History

XTX Topco’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$466K Buy
109,801
+3,409
+3% +$15.6K 0.01% 2527
2026
Q1 		$494K Buy
106,392
+58,718
+123% +$336K 0.01% 2064
2025
Q4 		$338K Buy
47,674
+36,026
+309% +$266K 0.01% 1963
2025
Q3 		$90.2K Buy
+11,648
New +$87.9K ﹤0.01% 2044
2024
Q3 		– Sell
-10,177
Closed -$206K – 2093
2024
Q2 		$206K Buy
+10,177
New +$230K 0.02% 1220

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

XTX Topco's BCYC Position: Q2 2026 in Review

XTX Topco increased its Bicycle Therapeutics (BCYC) stake by 3.2% in Q2 2026, buying an estimated $15.6K and bringing the position to 109,801 shares worth $466K. The position accounts for 0.01% of the portfolio, ranked #2527.

XTX Topco first reported a position in BCYC in Q2 2024 and has held it in 5 quarters since. The position peaked at $494K in Q1 2026. 103 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • XTX Topco held 109,801 shares of Bicycle Therapeutics worth $466K as of Q2 2026.
  • XTX Topco bought 3,409 Bicycle Therapeutics shares in Q2 2026, an estimated $15.6K.
  • Bicycle Therapeutics made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2527 holding.
  • XTX Topco first reported a position in Bicycle Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • XTX Topco's Bicycle Therapeutics position peaked at $494K in Q1 2026.
  • 103 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.